Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Two Step Therapeutics has secured a $6.5 million seed round led by NFX Bio. The company, founded by prominent scientists, aims to target solid tumors with its innovative platform. In a related development, Granza Bio has obtained $7.14 million in seed funding from Felicis and YC. Granza Bio, co-founded by Ashwin Nandakumar, Ashwin Jainarayanan, and Michael Dustin, focuses on advancing the delivery of cancer treatments and genetic medicine to specific tissue sites. Both companies are leveraging cutting-edge technology to combat cancer.
Everyone knows someone affected by cancer; it hijacks the body's systems and manipulates cellular processes. But what if we could utilize the body's most powerful natural weapon, the immune system, to fight back? We at @felicis are leading the Seed round of funding in…
Congrats to the @GranzaBio team on the $7.14M Seed! Founded by @Menon_Ashwin, @ak_jainarayanan, and @MichaelLDustin, Granza Bio (YC W24) is working to advance the delivery of cancer treatments and genetic medicine to specific tissue sites in our body. https://t.co/reVicphVqY https://t.co/2G11UsqQ2e
Everyone knows someone affected by cancer; it hijacks the body's systems and manipulates cellular processes. But what if we could utilize the body's most powerful natural weapon, the immune system, to fight back? We're leading the Seed round in @GranzaBio (YC W24), a company…